NCT01914380View on ClinicalTrials.gov

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

CompletedOBSERVATIONAL

Enrollment

988

Participants

Timeline

Start Date

July 29, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Patients will be followed-up for 24 months

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Bayer

INDUSTRY